Researching depression in prostate cancer patients: Factors, timing, and measures

Christopher F. Sharpley, Vicki Bitsika, David R H Christie, James W. Denham, Gillian M. Duchesne, Jeremy W. Couper

Research output: Contribution to journalReview articleResearchpeer-review

1 Citation (Scopus)

Abstract

Background: Due to the pressing need to understand the causal and associative factors of depression among prostate cancer (PCa) patients, a comprehensive research protocol for investigating depression in prostate cancer patients is suggested as a way of furthering the collection of data in consistent and informative ways. Methods: A detailed review of a range of predictors of, and buffers against, depression, plus methods of assessing depressive symptomatology and optimum time to collect data were used to develop a model for a comprehensive research protocol. Results: A model protocol is described that includes socioeconomic, genetic, endocrinal, immunological, physiological, psychological, relationship, and socioeconomic pathways to depression. In addition, methods of assessing depressive symptomatology are described, plus comorbidity of anxiety with depression, male depression, and the construct of Individual Burden of Illness for Depression. The need to collect multiple measures over time in order to describe variability in symptoms and the relationships between symptoms and other variables is emphasized. Conclusion: This model protocol of research into depression in prostate cancer patients allows for a comprehensive approach that includes predictors, symptoms, and time for observation. Use of this protocol will enhance the understanding and treatment of depression in PCa patients from a "personalized medicine" perspective.

Original languageEnglish
Pages (from-to)145-156
Number of pages12
JournalJournal of Men's Health
Volume11
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Prostatic Neoplasms
Depression
Research
Precision Medicine
Cost of Illness
Comorbidity
Buffers
Anxiety
Observation
Psychology

Cite this

Sharpley, C. F., Bitsika, V., Christie, D. R. H., Denham, J. W., Duchesne, G. M., & Couper, J. W. (2014). Researching depression in prostate cancer patients: Factors, timing, and measures. Journal of Men's Health, 11(4), 145-156. https://doi.org/10.1089/jomh.2014.0036
Sharpley, Christopher F. ; Bitsika, Vicki ; Christie, David R H ; Denham, James W. ; Duchesne, Gillian M. ; Couper, Jeremy W. / Researching depression in prostate cancer patients : Factors, timing, and measures. In: Journal of Men's Health. 2014 ; Vol. 11, No. 4. pp. 145-156.
@article{24e7a9b224f4435086c211788e905e40,
title = "Researching depression in prostate cancer patients: Factors, timing, and measures",
abstract = "Background: Due to the pressing need to understand the causal and associative factors of depression among prostate cancer (PCa) patients, a comprehensive research protocol for investigating depression in prostate cancer patients is suggested as a way of furthering the collection of data in consistent and informative ways. Methods: A detailed review of a range of predictors of, and buffers against, depression, plus methods of assessing depressive symptomatology and optimum time to collect data were used to develop a model for a comprehensive research protocol. Results: A model protocol is described that includes socioeconomic, genetic, endocrinal, immunological, physiological, psychological, relationship, and socioeconomic pathways to depression. In addition, methods of assessing depressive symptomatology are described, plus comorbidity of anxiety with depression, male depression, and the construct of Individual Burden of Illness for Depression. The need to collect multiple measures over time in order to describe variability in symptoms and the relationships between symptoms and other variables is emphasized. Conclusion: This model protocol of research into depression in prostate cancer patients allows for a comprehensive approach that includes predictors, symptoms, and time for observation. Use of this protocol will enhance the understanding and treatment of depression in PCa patients from a {"}personalized medicine{"} perspective.",
author = "Sharpley, {Christopher F.} and Vicki Bitsika and Christie, {David R H} and Denham, {James W.} and Duchesne, {Gillian M.} and Couper, {Jeremy W.}",
year = "2014",
doi = "10.1089/jomh.2014.0036",
language = "English",
volume = "11",
pages = "145--156",
journal = "Journal of Men's Health",
issn = "1875-6859",
publisher = "Elsevier",
number = "4",

}

Sharpley, CF, Bitsika, V, Christie, DRH, Denham, JW, Duchesne, GM & Couper, JW 2014, 'Researching depression in prostate cancer patients: Factors, timing, and measures' Journal of Men's Health, vol. 11, no. 4, pp. 145-156. https://doi.org/10.1089/jomh.2014.0036

Researching depression in prostate cancer patients : Factors, timing, and measures. / Sharpley, Christopher F.; Bitsika, Vicki; Christie, David R H; Denham, James W.; Duchesne, Gillian M.; Couper, Jeremy W.

In: Journal of Men's Health, Vol. 11, No. 4, 2014, p. 145-156.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Researching depression in prostate cancer patients

T2 - Factors, timing, and measures

AU - Sharpley, Christopher F.

AU - Bitsika, Vicki

AU - Christie, David R H

AU - Denham, James W.

AU - Duchesne, Gillian M.

AU - Couper, Jeremy W.

PY - 2014

Y1 - 2014

N2 - Background: Due to the pressing need to understand the causal and associative factors of depression among prostate cancer (PCa) patients, a comprehensive research protocol for investigating depression in prostate cancer patients is suggested as a way of furthering the collection of data in consistent and informative ways. Methods: A detailed review of a range of predictors of, and buffers against, depression, plus methods of assessing depressive symptomatology and optimum time to collect data were used to develop a model for a comprehensive research protocol. Results: A model protocol is described that includes socioeconomic, genetic, endocrinal, immunological, physiological, psychological, relationship, and socioeconomic pathways to depression. In addition, methods of assessing depressive symptomatology are described, plus comorbidity of anxiety with depression, male depression, and the construct of Individual Burden of Illness for Depression. The need to collect multiple measures over time in order to describe variability in symptoms and the relationships between symptoms and other variables is emphasized. Conclusion: This model protocol of research into depression in prostate cancer patients allows for a comprehensive approach that includes predictors, symptoms, and time for observation. Use of this protocol will enhance the understanding and treatment of depression in PCa patients from a "personalized medicine" perspective.

AB - Background: Due to the pressing need to understand the causal and associative factors of depression among prostate cancer (PCa) patients, a comprehensive research protocol for investigating depression in prostate cancer patients is suggested as a way of furthering the collection of data in consistent and informative ways. Methods: A detailed review of a range of predictors of, and buffers against, depression, plus methods of assessing depressive symptomatology and optimum time to collect data were used to develop a model for a comprehensive research protocol. Results: A model protocol is described that includes socioeconomic, genetic, endocrinal, immunological, physiological, psychological, relationship, and socioeconomic pathways to depression. In addition, methods of assessing depressive symptomatology are described, plus comorbidity of anxiety with depression, male depression, and the construct of Individual Burden of Illness for Depression. The need to collect multiple measures over time in order to describe variability in symptoms and the relationships between symptoms and other variables is emphasized. Conclusion: This model protocol of research into depression in prostate cancer patients allows for a comprehensive approach that includes predictors, symptoms, and time for observation. Use of this protocol will enhance the understanding and treatment of depression in PCa patients from a "personalized medicine" perspective.

UR - http://www.scopus.com/inward/record.url?scp=84911873109&partnerID=8YFLogxK

U2 - 10.1089/jomh.2014.0036

DO - 10.1089/jomh.2014.0036

M3 - Review article

VL - 11

SP - 145

EP - 156

JO - Journal of Men's Health

JF - Journal of Men's Health

SN - 1875-6859

IS - 4

ER -

Sharpley CF, Bitsika V, Christie DRH, Denham JW, Duchesne GM, Couper JW. Researching depression in prostate cancer patients: Factors, timing, and measures. Journal of Men's Health. 2014;11(4):145-156. https://doi.org/10.1089/jomh.2014.0036